Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byAbcam
Date3/2012

General Information

Offices

Burlingame, USA
863 Mitten Road
Suite 103
Burlingame, CA, 94010-1303
USA

People

CFO
President & CEO & Board Chairman
VP, In Vitro Diagnostics
VP, Business Services
Co - Founder & SVP, Antibody Technology

Tags

Epitomics

Epitomics, an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology for research and diagnostic applications. The company utilizes a unique and proprietary RabMAb® (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity, specificity and bioactivity both in vitro and in vivo. Epitomics, Inc. is headquartered in Burlingame, California, and operates wholly owned subsidiaries in Hong Kong and Hangzhou, the People’s Republic of China.

Recent Milestones

Videos

Screenshots

Sources

  1. Abcam to buy Epitomics of San Francisco for $170M (marketwatch.com) [edit]
Edit This Page
Last Edited 8/15/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy